Role of trans fatty acids in health and challenges to their reduction in Indian foods

被引:0
作者
Ghafoorunissa [1 ]
机构
[1] Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India
关键词
Indian edible oils/foods; hydrogenation; transfatty acids; diabetes; coronary heart disease;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Evidence indicates that dietary trans fatty acids (TFA) obtained from partially hydrogenated vegetable oils (PHVO) increase the risk of coronary heart disease (CHD). Studies have implicated TFA in increasing the risk and incidence of diabetes. Furthermore, TFA may compromise fetal and early infant growth and development. In rats, partial substitution of either linoleic acid (18:2 n-6) with saturated fatty acids (SFA, 6 en %) or SFA with TFA (3 en % from vanaspati) decreased peripheral insulin sensitivity, but these effects were greater in TFA group. Since a large proportion of Indian population is insulin resistant, the TFA content in Indian edible fats/oils and foods should be reduced. Vanaspati (PHVO) provides up to 40% TFA, is used in Indian cooking and in the preparation of commercially fried, processed, bakery, ready-to-eat and street foods. TFA in biscuits and sweets range 30-40 and 6-26% of total fatty acids respectively. There is no regulation on TFA content in vanaspati, bakery fats and shortenings. Reduction in Indian edible fats/oils and foods can be achieved by: a) specifying limits of TFA in vanaspati, bakery fats and shortenings by upgrading technology; b) advocating the substitution of natural plant oils containing lower percent of polyunsaturated fatty acids for PHVO. Indian edible oil industry needs to develop and adopt alternative technologies to produce zero TFA. Consumer education about negative health effects of TFA and providing food based guidelines to reduce TFA consumption in the entire population need to be actively pursued.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 15 条
  • [1] ACHAYA KT, 1987, J SCI IND RES INDIA, V46, P112
  • [2] ALLISON DB, 1995, AM J CLIN NUTR, V62, P655
  • [3] Elias SL, 2001, AM J CLIN NUTR, V73, P807
  • [4] Ghafoorunissa, 1998, INDIAN J MED RES, V108, P191
  • [5] Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats
    Ibrahim, A
    Natarajan, S
    Ghafoorunissa
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (02): : 240 - 246
  • [6] Korver O, 2006, NUTR REV, V64, P275, DOI [10.1301/nr.2006.jun.275-279, 10.1111/j.1753-4887.2006.tb00210.x]
  • [7] MEHTA BV, 2007, INDIAS EDIBLE OIL DE
  • [8] Medical progress - Trans fatty acids and cardiovascular disease
    Mozaffarian, D
    Katan, MB
    Ascherio, A
    Stampfer, MJ
    Willett, WC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) : 1601 - 1613
  • [9] NATARAJAN S, 2005, EUR J ENDOCRINOL, V153, P1
  • [10] Natarajan S, 2005, BR J NUTR, V93, P1